Language selection

Search

2015-03-10 - Male - 15 Years old

900271818

Adverse reaction report number 900271818
Latest AER version number 1
Market authorization holder AER number CA201501732
Initial received date 2015-03-10
Latest received date 2015-06-05
Age 15 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Physician
Source of report MAH
Report outcome Recovered/resolved
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral15 Milligram1 every 1 Day(s)1 Day(s)Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Hallucination, auditory2 Day(s)
Mental impairment2 Day(s)
Speech disorder2 Day(s)
Tic2 Day(s)
Tremor2 Day(s)
Wrong technique in product usage process2 Day(s)
Date modified: